D

Daiichi Sankyo

Tokyo, Japan Founded 2005 TSE: 4568
Nanomedicine Cancer Nanotherapy Drug Delivery Protein Nanoparticles Regenerative Medicine Nano-Bio

About

Antibody-drug conjugates and nanomedicine oncology

Company Details

Type
public
Employees
17000+
Funding
Public

Key Products

  • Enhertu
  • DXd Platform
Visit Website

Related Companies

N

Nanosphere (Luminex)

Northbrook, United States

N

NanoString Technologies

Seattle, United States

N

Nanobiotix

Paris, France

A

Arrowhead Research

Pasadena, United States